No Value to Sphincterotomy in Sphincter of Oddi Dysfunction Type III: Long-Term Follow-Up

ERCP with sphincterotomy should be avoided in patients with suspected SOD type III.

In a previous landmark trial, sphincterotomy was not better than a sham procedure in reducing disability from postcholecystectomy pain in patients who had undergone endoscopic retrograde cholangiopancreatography (ERCP) for sphincter of Oddi dysfunction (SOD) with no objective evidence of biliary obstruction (type III; JAMA 2014; 311:2101). The researchers concluded that their data did not support the use of ERCP and sphincterotomy for these patients. Now, long-term follow-up data are available from participants in the original trial and its successor observational study.

Using validated questionnaires administered by phone during a 5-year period after initial trial enrollment, researchers assessed a variety of physical and emotional symptoms…

Reviewing Author

Douglas G. Adler, MD

Disclosures

Consultant/Advisory BoardBSC; Merit; Olympus

Speaker’s BureauAbbVie

Editorial BoardsGastrointestinal Endoscopy

Douglas G. Adler, MD

Disclosures

Consultant/Advisory BoardBSC; Merit; Olympus

Speaker’s BureauAbbVie

Editorial BoardsGastrointestinal Endoscopy

No Value to Sphincterotomy in Sphincter of Oddi Dysfunction Type III: Long-Term Follow-Up

Topics

Reviewing Author